| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |